Harbinger Health Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Harbinger Health is a biotechnology research company based at 25 Spinelli Place, Cambridge, Massachusetts, United States, with 51-200 employees. It focuses on reducing the gap between clinical suspicion and cancer diagnosis by developing a new category of blood-based diagnostics that combine blood testing with advanced analytics, organized under the RESOLVE portfolio. The company launched RESOLVE in April 2026, with first products expected to be commercially available in the second half of 2026, and it aims to provide multi-cancer detection capabilities. It has presented clinical data at the ASCO Annual Meeting in 2026 supporting RESOLVE and related methylation-based approaches, and is developing models to infer lung cancer progression from cfDNA methylation data. Financially, the company reports revenue in the range of $25-50 million and has raised about $140 million in funding, and Ajit Singh was appointed chief executive officer in August 2025.

Sign up for free to view info

Company overview Employee directory